

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium movement (GO:0003341) | 6.99716423 |
| 2 | response to muscle activity (GO:0014850) | 6.58318135 |
| 3 | axoneme assembly (GO:0035082) | 5.74984723 |
| 4 | glyoxylate metabolic process (GO:0046487) | 5.58404741 |
| 5 | axonemal dynein complex assembly (GO:0070286) | 5.48116997 |
| 6 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.45446540 |
| 7 | central nervous system myelination (GO:0022010) | 5.41803630 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 5.41803630 |
| 9 | regulation of oxidative phosphorylation (GO:0002082) | 5.40215548 |
| 10 | ventricular system development (GO:0021591) | 5.16448918 |
| 11 | AMP metabolic process (GO:0046033) | 5.09136849 |
| 12 | epithelial cilium movement (GO:0003351) | 4.80922397 |
| 13 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.76702551 |
| 14 | GTP biosynthetic process (GO:0006183) | 4.76114815 |
| 15 | ADP metabolic process (GO:0046031) | 4.75812787 |
| 16 | activation of protein kinase B activity (GO:0032148) | 4.67674875 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 4.67442276 |
| 18 | cellular response to zinc ion (GO:0071294) | 4.61030868 |
| 19 | nucleoside diphosphate phosphorylation (GO:0006165) | 4.48904400 |
| 20 | muscle filament sliding (GO:0030049) | 4.33672745 |
| 21 | actin-myosin filament sliding (GO:0033275) | 4.33672745 |
| 22 | coenzyme catabolic process (GO:0009109) | 4.25617909 |
| 23 | positive regulation of catecholamine secretion (GO:0033605) | 4.19490446 |
| 24 | UTP metabolic process (GO:0046051) | 4.08304073 |
| 25 | UTP biosynthetic process (GO:0006228) | 4.04654938 |
| 26 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.91531918 |
| 27 | cellular response to cadmium ion (GO:0071276) | 3.85386611 |
| 28 | glycine metabolic process (GO:0006544) | 3.79337572 |
| 29 | muscle cell cellular homeostasis (GO:0046716) | 3.70201710 |
| 30 | myofibril assembly (GO:0030239) | 3.63798346 |
| 31 | regulation of cellular respiration (GO:0043457) | 3.59151998 |
| 32 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.57183121 |
| 33 | CTP metabolic process (GO:0046036) | 3.50287358 |
| 34 | CTP biosynthetic process (GO:0006241) | 3.50287358 |
| 35 | polyketide metabolic process (GO:0030638) | 3.49667317 |
| 36 | doxorubicin metabolic process (GO:0044598) | 3.49667317 |
| 37 | daunorubicin metabolic process (GO:0044597) | 3.49667317 |
| 38 | actin-mediated cell contraction (GO:0070252) | 3.48689131 |
| 39 | regulation of autophagic vacuole assembly (GO:2000785) | 3.48247626 |
| 40 | fructose metabolic process (GO:0006000) | 3.40793355 |
| 41 | uronic acid metabolic process (GO:0006063) | 3.30210143 |
| 42 | glucuronate metabolic process (GO:0019585) | 3.30210143 |
| 43 | epoxygenase P450 pathway (GO:0019373) | 3.27087203 |
| 44 | cellular glucuronidation (GO:0052695) | 3.25664839 |
| 45 | xenobiotic catabolic process (GO:0042178) | 3.20327487 |
| 46 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.16090121 |
| 47 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.15157733 |
| 48 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.14788413 |
| 49 | protein carboxylation (GO:0018214) | 3.14788413 |
| 50 | left/right axis specification (GO:0070986) | 3.13069895 |
| 51 | phenylpropanoid metabolic process (GO:0009698) | 3.13056119 |
| 52 | glycogen metabolic process (GO:0005977) | 3.11341368 |
| 53 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.10088740 |
| 54 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.09647776 |
| 55 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.06271945 |
| 56 | ether lipid metabolic process (GO:0046485) | 3.05911234 |
| 57 | ribosome assembly (GO:0042255) | 3.05055864 |
| 58 | nerve growth factor signaling pathway (GO:0038180) | 3.05045610 |
| 59 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.04881465 |
| 60 | sarcomere organization (GO:0045214) | 3.03737329 |
| 61 | glucan metabolic process (GO:0044042) | 3.03520288 |
| 62 | cellular glucan metabolic process (GO:0006073) | 3.03520288 |
| 63 | carnitine shuttle (GO:0006853) | 3.03192218 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 3.03038323 |
| 65 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.02390087 |
| 66 | rRNA modification (GO:0000154) | 3.00139001 |
| 67 | NADH metabolic process (GO:0006734) | 2.98303868 |
| 68 | response to mercury ion (GO:0046689) | 2.97822714 |
| 69 | TOR signaling (GO:0031929) | 2.96117435 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 2.95311434 |
| 71 | omega-hydroxylase P450 pathway (GO:0097267) | 2.94690139 |
| 72 | intraciliary transport (GO:0042073) | 2.93279374 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 2.93240627 |
| 74 | ensheathment of neurons (GO:0007272) | 2.92858227 |
| 75 | axon ensheathment (GO:0008366) | 2.92858227 |
| 76 | myelination (GO:0042552) | 2.92177299 |
| 77 | L-fucose catabolic process (GO:0042355) | 2.92130623 |
| 78 | fucose catabolic process (GO:0019317) | 2.92130623 |
| 79 | L-fucose metabolic process (GO:0042354) | 2.92130623 |
| 80 | DNA double-strand break processing (GO:0000729) | 2.91864558 |
| 81 | L-methionine salvage (GO:0071267) | 2.90937337 |
| 82 | L-methionine biosynthetic process (GO:0071265) | 2.90937337 |
| 83 | amino acid salvage (GO:0043102) | 2.90937337 |
| 84 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.89847004 |
| 85 | carnitine transport (GO:0015879) | 2.89311567 |
| 86 | amino-acid betaine transport (GO:0015838) | 2.89311567 |
| 87 | uterus development (GO:0060065) | 2.88447466 |
| 88 | cofactor catabolic process (GO:0051187) | 2.88320771 |
| 89 | regulation of fibrinolysis (GO:0051917) | 2.88088054 |
| 90 | skeletal muscle contraction (GO:0003009) | 2.87775895 |
| 91 | microtubule bundle formation (GO:0001578) | 2.87633521 |
| 92 | quinone metabolic process (GO:1901661) | 2.86192848 |
| 93 | regulation of skeletal muscle contraction (GO:0014819) | 2.83274527 |
| 94 | urea metabolic process (GO:0019627) | 2.83084045 |
| 95 | creatine metabolic process (GO:0006600) | 2.81724351 |
| 96 | myelin maintenance (GO:0043217) | 2.81186667 |
| 97 | fatty acid transmembrane transport (GO:1902001) | 2.78513006 |
| 98 | heme transport (GO:0015886) | 2.77793834 |
| 99 | oligodendrocyte differentiation (GO:0048709) | 2.77760441 |
| 100 | import into cell (GO:0098657) | 2.77256588 |
| 101 | cilium morphogenesis (GO:0060271) | 2.74259462 |
| 102 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.72154847 |
| 103 | bile acid biosynthetic process (GO:0006699) | 2.71870169 |
| 104 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.71774734 |
| 105 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 2.70492985 |
| 106 | oxidative demethylation (GO:0070989) | 2.69867766 |
| 107 | cysteine metabolic process (GO:0006534) | 2.69691531 |
| 108 | regulation of vacuole organization (GO:0044088) | 2.69517870 |
| 109 | eye photoreceptor cell differentiation (GO:0001754) | 2.67946771 |
| 110 | photoreceptor cell differentiation (GO:0046530) | 2.67946771 |
| 111 | glycogen catabolic process (GO:0005980) | 2.67175335 |
| 112 | branched-chain amino acid catabolic process (GO:0009083) | 2.66560377 |
| 113 | fatty acid elongation (GO:0030497) | 2.66314390 |
| 114 | peptidyl-histidine modification (GO:0018202) | 2.66119014 |
| 115 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.66014755 |
| 116 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.65465618 |
| 117 | alpha-amino acid catabolic process (GO:1901606) | 2.64322860 |
| 118 | tricarboxylic acid cycle (GO:0006099) | 2.63527435 |
| 119 | L-amino acid import (GO:0043092) | 2.63482826 |
| 120 | drug catabolic process (GO:0042737) | 2.63446806 |
| 121 | carnitine transmembrane transport (GO:1902603) | 2.63289984 |
| 122 | quaternary ammonium group transport (GO:0015697) | 2.62597715 |
| 123 | fatty acid homeostasis (GO:0055089) | 2.62435322 |
| 124 | glycogen biosynthetic process (GO:0005978) | 2.61373059 |
| 125 | glucan biosynthetic process (GO:0009250) | 2.61373059 |
| 126 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.60450934 |
| 127 | nucleotide phosphorylation (GO:0046939) | 2.59715307 |
| 128 | positive regulation of glycolytic process (GO:0045821) | 2.59590295 |
| 129 | androgen biosynthetic process (GO:0006702) | 2.59093130 |
| 130 | mitochondrion morphogenesis (GO:0070584) | 2.58409966 |
| 131 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.58011457 |
| 132 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.57861397 |
| 133 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.57503785 |
| 134 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.56949956 |
| 135 | carnitine metabolic process (GO:0009437) | 2.56905783 |
| 136 | cytolysis (GO:0019835) | 2.56208612 |
| 137 | very long-chain fatty acid metabolic process (GO:0000038) | 2.56064318 |
| 138 | skeletal muscle fiber development (GO:0048741) | 2.55484848 |
| 139 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.54357395 |
| 140 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.52377813 |
| 141 | opsonization (GO:0008228) | 2.51557145 |
| 142 | progesterone metabolic process (GO:0042448) | 2.51272019 |
| 143 | response to methylmercury (GO:0051597) | 2.49456098 |
| 144 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.47480903 |
| 145 | positive regulation of respiratory burst (GO:0060267) | 2.47359847 |
| 146 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.47233282 |
| 147 | neurotransmitter uptake (GO:0001504) | 2.45598825 |
| 148 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.44579617 |
| 149 | L-phenylalanine catabolic process (GO:0006559) | 2.44579617 |
| 150 | L-serine transport (GO:0015825) | 2.44342641 |
| 151 | L-phenylalanine metabolic process (GO:0006558) | 2.44069446 |
| 152 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.44069446 |
| 153 | regulation of cholesterol esterification (GO:0010872) | 2.43971680 |
| 154 | negative regulation of neurotransmitter transport (GO:0051589) | 2.41254246 |
| 155 | drug transmembrane transport (GO:0006855) | 2.40511642 |
| 156 | succinate metabolic process (GO:0006105) | 2.40001315 |
| 157 | thioester biosynthetic process (GO:0035384) | 2.38952693 |
| 158 | acyl-CoA biosynthetic process (GO:0071616) | 2.38952693 |
| 159 | motile cilium assembly (GO:0044458) | 2.35910104 |
| 160 | negative regulation of astrocyte differentiation (GO:0048712) | 2.33779434 |
| 161 | cilium organization (GO:0044782) | 2.33535860 |
| 162 | fucose metabolic process (GO:0006004) | 2.32133407 |
| 163 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.30521549 |
| 164 | peptide biosynthetic process (GO:0043043) | 2.30389091 |
| 165 | protein palmitoylation (GO:0018345) | 2.28911253 |
| 166 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.28564565 |
| 167 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.28491802 |
| 168 | presynaptic membrane assembly (GO:0097105) | 2.27829872 |
| 169 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.27313005 |
| 170 | cellular ketone body metabolic process (GO:0046950) | 2.23404714 |
| 171 | acetyl-CoA metabolic process (GO:0006084) | 2.23249778 |
| 172 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.22966397 |
| 173 | nucleoside diphosphate metabolic process (GO:0009132) | 2.21550383 |
| 174 | aspartate family amino acid catabolic process (GO:0009068) | 2.19158346 |
| 175 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.18176641 |
| 176 | neuron remodeling (GO:0016322) | 2.18145481 |
| 177 | regulation of pigment cell differentiation (GO:0050932) | 2.17241567 |
| 178 | pyrimidine ribonucleotide metabolic process (GO:0009218) | 2.16544447 |
| 179 | toxin transport (GO:1901998) | 2.15349515 |
| 180 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.14670849 |
| 181 | neurotransmitter catabolic process (GO:0042135) | 2.14096759 |
| 182 | cilium assembly (GO:0042384) | 2.13280885 |
| 183 | asymmetric protein localization (GO:0008105) | 2.13002295 |
| 184 | fatty acid beta-oxidation (GO:0006635) | 2.12498804 |
| 185 | fatty acid catabolic process (GO:0009062) | 2.11865012 |
| 186 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 2.11303018 |
| 187 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.10155557 |
| 188 | regulation of coenzyme metabolic process (GO:0051196) | 2.09133980 |
| 189 | regulation of cofactor metabolic process (GO:0051193) | 2.09133980 |
| 190 | oxygen transport (GO:0015671) | 2.09039567 |
| 191 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.08945135 |
| 192 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.08021236 |
| 193 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 2.06951061 |
| 194 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.06927199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.30862716 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.47444567 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.23552878 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.15292792 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.70376444 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08419531 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.84477185 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.82727832 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.74016013 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.46963683 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.35450461 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.27660399 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.15774004 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.11152565 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.09747280 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.06917258 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03265953 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01389731 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97222470 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.97129392 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96396421 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87086158 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86386693 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86386693 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.85758333 |
| 26 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.82646607 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81607365 |
| 28 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80530884 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.78582513 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78205941 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77283765 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.76968984 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76301519 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74683347 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73148177 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70385909 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69983502 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.68538445 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.66818394 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66755295 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64326917 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61149748 |
| 43 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.59303443 |
| 44 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.51535640 |
| 45 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.51527087 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49416790 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47674419 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47023015 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.46654964 |
| 50 | CBP_21632823_ChIP-Seq_H3396_Human | 1.45460696 |
| 51 | RXR_22108803_ChIP-Seq_LS180_Human | 1.44651494 |
| 52 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44448811 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44346889 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42900775 |
| 55 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.42594805 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41636014 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41636014 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39470761 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.38953191 |
| 60 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.38479856 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37329732 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37122607 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35142225 |
| 64 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.34836921 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34544537 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34544537 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34409422 |
| 68 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34061820 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34033430 |
| 70 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.32497499 |
| 71 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32336753 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32080605 |
| 73 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.31928127 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.30839820 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30017830 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27738689 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26457503 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25815733 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25739958 |
| 80 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25561297 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25337478 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24508749 |
| 83 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.24474536 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.23965616 |
| 85 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23170190 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22943248 |
| 87 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.21366875 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20068737 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19753068 |
| 90 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19676804 |
| 91 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.18977017 |
| 92 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17944708 |
| 93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17838013 |
| 94 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16361296 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16150960 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15978019 |
| 97 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15563492 |
| 98 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15410064 |
| 99 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.14553471 |
| 100 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14017087 |
| 101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13447397 |
| 102 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13139636 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10849414 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10437686 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10132163 |
| 106 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09952930 |
| 107 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09165944 |
| 108 | TBL1_22424771_ChIP-Seq_293T_Human | 1.09043469 |
| 109 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07740122 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07027832 |
| 111 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.06934950 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06050211 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04444956 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04342235 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03849584 |
| 116 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.03317376 |
| 117 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03270180 |
| 118 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02909237 |
| 119 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02454958 |
| 120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02216450 |
| 121 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01793059 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01706158 |
| 123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01151554 |
| 124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01033516 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00904019 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00071969 |
| 127 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99467649 |
| 128 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.98518056 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98022049 |
| 130 | NFYB_21822215_ChIP-Seq_K562_Human | 0.97234603 |
| 131 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97155013 |
| 132 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96796561 |
| 133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96362386 |
| 134 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.96347697 |
| 135 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95862655 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95826512 |
| 137 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95826512 |
| 138 | NFYA_21822215_ChIP-Seq_K562_Human | 0.95786518 |
| 139 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95166321 |
| 140 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94912409 |
| 141 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94559353 |
| 142 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94190710 |
| 143 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93783743 |
| 144 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93548519 |
| 145 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92638555 |
| 146 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92325259 |
| 147 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92318637 |
| 148 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91950117 |
| 149 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91920247 |
| 150 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.91886507 |
| 151 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.91259462 |
| 152 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.91205229 |
| 153 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.90023989 |
| 154 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89888419 |
| 155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89252008 |
| 156 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.88812442 |
| 157 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88520586 |
| 158 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87646421 |
| 159 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.87605640 |
| 160 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.87325051 |
| 161 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87231914 |
| 162 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87060221 |
| 163 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86972742 |
| 164 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86504225 |
| 165 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86370191 |
| 166 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86117741 |
| 167 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.85867593 |
| 168 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85667100 |
| 169 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84618469 |
| 170 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84608587 |
| 171 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84440276 |
| 172 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84418347 |
| 173 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82933889 |
| 174 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82115595 |
| 175 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82115595 |
| 176 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.81761086 |
| 177 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.81508103 |
| 178 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81288133 |
| 179 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.80998191 |
| 180 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.80673572 |
| 181 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.80530743 |
| 182 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.80222277 |
| 183 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79503005 |
| 184 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.78832667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 3.68778649 |
| 2 | MP0005623_abnormal_meninges_morphology | 2.87615873 |
| 3 | MP0006036_abnormal_mitochondrial_physio | 2.73171929 |
| 4 | MP0004270_analgesia | 2.64172338 |
| 5 | MP0004885_abnormal_endolymph | 2.49980031 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 2.44377677 |
| 7 | MP0002254_reproductive_system_inflammat | 2.40193660 |
| 8 | MP0005360_urolithiasis | 2.38926007 |
| 9 | MP0005451_abnormal_body_composition | 2.32363065 |
| 10 | MP0005330_cardiomyopathy | 2.31767956 |
| 11 | MP0001188_hyperpigmentation | 2.29821478 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.28126109 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.27615434 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.18586306 |
| 15 | MP0002269_muscular_atrophy | 2.13898467 |
| 16 | MP0003690_abnormal_glial_cell | 2.13317118 |
| 17 | MP0000920_abnormal_myelination | 2.11803708 |
| 18 | MP0003880_abnormal_central_pattern | 2.07829341 |
| 19 | MP0003195_calcinosis | 2.03916005 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.02980217 |
| 21 | MP0003941_abnormal_skin_development | 2.01066722 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 2.00886061 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.00168478 |
| 24 | MP0002009_preneoplasia | 2.00036511 |
| 25 | MP0004147_increased_porphyrin_level | 1.99781271 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 1.98606976 |
| 27 | MP0004043_abnormal_pH_regulation | 1.98451514 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 1.97536777 |
| 29 | MP0004233_abnormal_muscle_weight | 1.94147548 |
| 30 | MP0005332_abnormal_amino_acid | 1.87755691 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.87529180 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.87371879 |
| 33 | MP0002160_abnormal_reproductive_system | 1.87177671 |
| 34 | MP0009840_abnormal_foam_cell | 1.87175489 |
| 35 | MP0003646_muscle_fatigue | 1.83228372 |
| 36 | MP0008004_abnormal_stomach_pH | 1.83156717 |
| 37 | MP0003315_abnormal_perineum_morphology | 1.76582065 |
| 38 | MP0000747_muscle_weakness | 1.74029368 |
| 39 | MP0001765_abnormal_ion_homeostasis | 1.70187249 |
| 40 | MP0002272_abnormal_nervous_system | 1.68380974 |
| 41 | MP0001984_abnormal_olfaction | 1.66596412 |
| 42 | MP0003635_abnormal_synaptic_transmissio | 1.64358432 |
| 43 | MP0009046_muscle_twitch | 1.63376088 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.60559437 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.58019863 |
| 46 | MP0002064_seizures | 1.54129399 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.54094050 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.53081031 |
| 49 | MP0001486_abnormal_startle_reflex | 1.52009295 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 1.51755424 |
| 51 | MP0003634_abnormal_glial_cell | 1.51442253 |
| 52 | MP0001764_abnormal_homeostasis | 1.49831649 |
| 53 | MP0003123_paternal_imprinting | 1.49129070 |
| 54 | MP0003633_abnormal_nervous_system | 1.45031108 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.44958170 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.44328477 |
| 57 | MP0009745_abnormal_behavioral_response | 1.43423450 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.41592866 |
| 59 | MP0003252_abnormal_bile_duct | 1.41067235 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.40495627 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.37437816 |
| 62 | MP0002127_abnormal_cardiovascular_syste | 1.37164480 |
| 63 | MP0005365_abnormal_bile_salt | 1.36880967 |
| 64 | MP0005620_abnormal_muscle_contractility | 1.34520931 |
| 65 | MP0001666_abnormal_nutrient_absorption | 1.34146288 |
| 66 | MP0004133_heterotaxia | 1.34125964 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.33813053 |
| 68 | MP0000749_muscle_degeneration | 1.32689594 |
| 69 | MP0002736_abnormal_nociception_after | 1.31706354 |
| 70 | MP0000759_abnormal_skeletal_muscle | 1.30908781 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.30394017 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 1.29438478 |
| 73 | MP0001661_extended_life_span | 1.27744553 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.27717648 |
| 75 | MP0002090_abnormal_vision | 1.27050727 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.26276627 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.26138742 |
| 78 | MP0005266_abnormal_metabolism | 1.25159102 |
| 79 | MP0010329_abnormal_lipoprotein_level | 1.19587244 |
| 80 | MP0001905_abnormal_dopamine_level | 1.17385584 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.17111642 |
| 82 | MP0005410_abnormal_fertilization | 1.16789646 |
| 83 | MP0001873_stomach_inflammation | 1.16568018 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.16076972 |
| 85 | MP0001501_abnormal_sleep_pattern | 1.15646256 |
| 86 | MP0002909_abnormal_adrenal_gland | 1.15606786 |
| 87 | MP0001299_abnormal_eye_distance/ | 1.15084716 |
| 88 | MP0008569_lethality_at_weaning | 1.13115860 |
| 89 | MP0003329_amyloid_beta_deposits | 1.12811245 |
| 90 | MP0003718_maternal_effect | 1.12521396 |
| 91 | MP0001958_emphysema | 1.11988005 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 1.11131278 |
| 93 | MP0002067_abnormal_sensory_capabilities | 1.10078212 |
| 94 | MP0005647_abnormal_sex_gland | 1.09519851 |
| 95 | MP0002063_abnormal_learning/memory/cond | 1.08065547 |
| 96 | MP0002229_neurodegeneration | 1.06940288 |
| 97 | MP0005670_abnormal_white_adipose | 1.05963846 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05566666 |
| 99 | MP0005389_reproductive_system_phenotype | 1.05143411 |
| 100 | MP0009697_abnormal_copulation | 1.04452063 |
| 101 | MP0004142_abnormal_muscle_tone | 1.02258334 |
| 102 | MP0002557_abnormal_social/conspecific_i | 1.00185707 |
| 103 | MP0003868_abnormal_feces_composition | 0.98697776 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.97105022 |
| 105 | MP0003631_nervous_system_phenotype | 0.95583026 |
| 106 | MP0000778_abnormal_nervous_system | 0.95410483 |
| 107 | MP0009250_abnormal_appendicular_skeleto | 0.94793228 |
| 108 | MP0005409_darkened_coat_color | 0.94533458 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.93175793 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.92782036 |
| 111 | MP0000751_myopathy | 0.90741097 |
| 112 | MP0002928_abnormal_bile_duct | 0.90668921 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.89802317 |
| 114 | MP0004858_abnormal_nervous_system | 0.88168270 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.88052507 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.87797680 |
| 117 | MP0003806_abnormal_nucleotide_metabolis | 0.86313341 |
| 118 | MP0001664_abnormal_digestion | 0.85816617 |
| 119 | MP0001756_abnormal_urination | 0.85790937 |
| 120 | MP0000955_abnormal_spinal_cord | 0.85530181 |
| 121 | MP0002108_abnormal_muscle_morphology | 0.84843250 |
| 122 | MP0001529_abnormal_vocalization | 0.84715896 |
| 123 | MP0002882_abnormal_neuron_morphology | 0.83374124 |
| 124 | MP0002938_white_spotting | 0.83286054 |
| 125 | MP0002078_abnormal_glucose_homeostasis | 0.83166801 |
| 126 | MP0004742_abnormal_vestibular_system | 0.83139264 |
| 127 | MP0001502_abnormal_circadian_rhythm | 0.83124662 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.82309704 |
| 129 | MP0009643_abnormal_urine_homeostasis | 0.82279184 |
| 130 | MP0002972_abnormal_cardiac_muscle | 0.81927854 |
| 131 | MP0002822_catalepsy | 0.79533139 |
| 132 | MP0005310_abnormal_salivary_gland | 0.79523937 |
| 133 | MP0001663_abnormal_digestive_system | 0.79452811 |
| 134 | MP0005381_digestive/alimentary_phenotyp | 0.78958442 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.78705013 |
| 136 | MP0004036_abnormal_muscle_relaxation | 0.78669113 |
| 137 | MP0001544_abnormal_cardiovascular_syste | 0.78536852 |
| 138 | MP0005385_cardiovascular_system_phenoty | 0.78536852 |
| 139 | MP0005369_muscle_phenotype | 0.78501601 |
| 140 | MP0005319_abnormal_enzyme/_coenzyme | 0.78092937 |
| 141 | MP0001919_abnormal_reproductive_system | 0.77774514 |
| 142 | MP0005187_abnormal_penis_morphology | 0.77757835 |
| 143 | MP0004134_abnormal_chest_morphology | 0.77471182 |
| 144 | MP0003186_abnormal_redox_activity | 0.77163874 |
| 145 | MP0002876_abnormal_thyroid_physiology | 0.75236841 |
| 146 | MP0010368_abnormal_lymphatic_system | 0.75123408 |
| 147 | MP0002102_abnormal_ear_morphology | 0.74973681 |
| 148 | MP0008775_abnormal_heart_ventricle | 0.73928437 |
| 149 | MP0004130_abnormal_muscle_cell | 0.72526360 |
| 150 | MP0001881_abnormal_mammary_gland | 0.72216827 |
| 151 | MP0002133_abnormal_respiratory_system | 0.72185041 |
| 152 | MP0010630_abnormal_cardiac_muscle | 0.72162613 |
| 153 | MP0005253_abnormal_eye_physiology | 0.71855722 |
| 154 | MP0009672_abnormal_birth_weight | 0.71366210 |
| 155 | MP0004272_abnormal_basement_membrane | 0.70470156 |
| 156 | MP0002138_abnormal_hepatobiliary_system | 0.68644346 |
| 157 | MP0008007_abnormal_cellular_replicative | 0.67575941 |
| 158 | MP0005376_homeostasis/metabolism_phenot | 0.65895942 |
| 159 | MP0003283_abnormal_digestive_organ | 0.60321211 |
| 160 | MP0002796_impaired_skin_barrier | 0.57660695 |
| 161 | MP0003936_abnormal_reproductive_system | 0.57214341 |
| 162 | MP0002106_abnormal_muscle_physiology | 0.56554890 |
| 163 | MP0001944_abnormal_pancreas_morphology | 0.53843089 |
| 164 | MP0003011_delayed_dark_adaptation | 0.53306615 |
| 165 | MP0005334_abnormal_fat_pad | 0.53134400 |
| 166 | MP0008058_abnormal_DNA_repair | 0.51247224 |
| 167 | MP0000762_abnormal_tongue_morphology | 0.49637486 |
| 168 | MP0000609_abnormal_liver_physiology | 0.48208644 |
| 169 | MP0000462_abnormal_digestive_system | 0.48174701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 8.24499616 |
| 2 | Abnormal ciliary motility (HP:0012262) | 8.01874448 |
| 3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 7.98288438 |
| 4 | Rhinitis (HP:0012384) | 6.08477177 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 5.61599623 |
| 6 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.41415328 |
| 7 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.41415328 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 5.19176213 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.18246016 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.99572325 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.67091504 |
| 12 | Absent/shortened dynein arms (HP:0200106) | 4.67091504 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.39640714 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 4.33982608 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.33180729 |
| 16 | Nemaline bodies (HP:0003798) | 4.18716286 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 4.16749617 |
| 18 | Chronic bronchitis (HP:0004469) | 3.88336897 |
| 19 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.87069547 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 3.85478358 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 3.80400414 |
| 22 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.59166869 |
| 23 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.59166869 |
| 24 | Rimmed vacuoles (HP:0003805) | 3.52569065 |
| 25 | Deep venous thrombosis (HP:0002625) | 3.51749771 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.39970177 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.37783492 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.26065709 |
| 29 | Hypoglycemic seizures (HP:0002173) | 3.23723596 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.23022405 |
| 31 | Bronchiectasis (HP:0002110) | 3.17943173 |
| 32 | Neck muscle weakness (HP:0000467) | 3.17245189 |
| 33 | Proximal amyotrophy (HP:0007126) | 3.10480840 |
| 34 | Abnormality of the shoulder girdle musculature (HP:0001435) | 3.09979298 |
| 35 | Bile duct proliferation (HP:0001408) | 3.09402346 |
| 36 | Abnormal biliary tract physiology (HP:0012439) | 3.09402346 |
| 37 | Back pain (HP:0003418) | 2.95363418 |
| 38 | Clumsiness (HP:0002312) | 2.91495040 |
| 39 | Abnormal drinking behavior (HP:0030082) | 2.90304182 |
| 40 | Polydipsia (HP:0001959) | 2.90304182 |
| 41 | Retinal dysplasia (HP:0007973) | 2.89749161 |
| 42 | Myoglobinuria (HP:0002913) | 2.89465323 |
| 43 | Scapular winging (HP:0003691) | 2.77370297 |
| 44 | Increased circulating renin level (HP:0000848) | 2.77141998 |
| 45 | Pancreatic cysts (HP:0001737) | 2.77033733 |
| 46 | Muscle fiber splitting (HP:0003555) | 2.74866902 |
| 47 | Pancreatic fibrosis (HP:0100732) | 2.74863180 |
| 48 | Bulbar palsy (HP:0001283) | 2.71057460 |
| 49 | Abnormality of the corticospinal tract (HP:0002492) | 2.71030576 |
| 50 | Right ventricular cardiomyopathy (HP:0011663) | 2.68118247 |
| 51 | Resting tremor (HP:0002322) | 2.66189554 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.59136187 |
| 53 | Abnormality of glycine metabolism (HP:0010895) | 2.59136187 |
| 54 | Ketoacidosis (HP:0001993) | 2.56831410 |
| 55 | Limb-girdle muscle atrophy (HP:0003797) | 2.56655268 |
| 56 | Abnormal pancreas size (HP:0012094) | 2.55784547 |
| 57 | Distal arthrogryposis (HP:0005684) | 2.54403809 |
| 58 | Symptomatic seizures (HP:0011145) | 2.53853820 |
| 59 | Metabolic alkalosis (HP:0200114) | 2.52836656 |
| 60 | Male infertility (HP:0003251) | 2.52540757 |
| 61 | Abnormal urine output (HP:0012590) | 2.49926278 |
| 62 | Scanning speech (HP:0002168) | 2.49003889 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.48811913 |
| 64 | Myopathic facies (HP:0002058) | 2.47311589 |
| 65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.47054826 |
| 66 | Neoplasm of the adrenal gland (HP:0100631) | 2.45012631 |
| 67 | Hepatoblastoma (HP:0002884) | 2.42222579 |
| 68 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.41679267 |
| 69 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.41679267 |
| 70 | Cystic liver disease (HP:0006706) | 2.41678032 |
| 71 | Polyuria (HP:0000103) | 2.40755701 |
| 72 | Muscular dystrophy (HP:0003560) | 2.40362112 |
| 73 | True hermaphroditism (HP:0010459) | 2.40298318 |
| 74 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.38811460 |
| 75 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.38811460 |
| 76 | Malignant hyperthermia (HP:0002047) | 2.37860290 |
| 77 | Spinal rigidity (HP:0003306) | 2.34821708 |
| 78 | Abnormality of methionine metabolism (HP:0010901) | 2.34810635 |
| 79 | Hypoglycemic coma (HP:0001325) | 2.34290165 |
| 80 | Acute encephalopathy (HP:0006846) | 2.32414734 |
| 81 | Hypobetalipoproteinemia (HP:0003563) | 2.31554922 |
| 82 | Hyperglycinuria (HP:0003108) | 2.29488541 |
| 83 | Hyperventilation (HP:0002883) | 2.28990025 |
| 84 | Acute necrotizing encephalopathy (HP:0006965) | 2.28806344 |
| 85 | Retinal atrophy (HP:0001105) | 2.27634628 |
| 86 | Type I transferrin isoform profile (HP:0003642) | 2.26763534 |
| 87 | Weak cry (HP:0001612) | 2.25265326 |
| 88 | Cerebral hypomyelination (HP:0006808) | 2.22933425 |
| 89 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.22696123 |
| 90 | Medial flaring of the eyebrow (HP:0010747) | 2.18718332 |
| 91 | Abnormal glycosylation (HP:0012345) | 2.18705792 |
| 92 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.18705792 |
| 93 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.18705792 |
| 94 | Abnormal protein glycosylation (HP:0012346) | 2.18705792 |
| 95 | Frequent falls (HP:0002359) | 2.17098058 |
| 96 | Ketosis (HP:0001946) | 2.16398844 |
| 97 | Abnormality of serum amino acid levels (HP:0003112) | 2.16225643 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.15722974 |
| 99 | Hypomagnesemia (HP:0002917) | 2.15119513 |
| 100 | Abnormality of renal excretion (HP:0011036) | 2.13324792 |
| 101 | Cerebral edema (HP:0002181) | 2.12128600 |
| 102 | Gait imbalance (HP:0002141) | 2.11932195 |
| 103 | Increased intramyocellular lipid droplets (HP:0012240) | 2.10859265 |
| 104 | Difficulty climbing stairs (HP:0003551) | 2.10665990 |
| 105 | Intention tremor (HP:0002080) | 2.10658823 |
| 106 | Increased serum pyruvate (HP:0003542) | 2.09780108 |
| 107 | Termporal pattern (HP:0011008) | 2.09723630 |
| 108 | Insidious onset (HP:0003587) | 2.09723630 |
| 109 | Pheochromocytoma (HP:0002666) | 2.09490216 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.09471257 |
| 111 | Oligomenorrhea (HP:0000876) | 2.09396619 |
| 112 | Renal Fanconi syndrome (HP:0001994) | 2.08592134 |
| 113 | Increased CSF lactate (HP:0002490) | 2.08429981 |
| 114 | Congenital primary aphakia (HP:0007707) | 2.07619381 |
| 115 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06023467 |
| 116 | Type 1 muscle fiber predominance (HP:0003803) | 2.03319320 |
| 117 | Hyperglycemia (HP:0003074) | 2.03184327 |
| 118 | Enlarged kidneys (HP:0000105) | 2.01138572 |
| 119 | Methylmalonic acidemia (HP:0002912) | 2.00983774 |
| 120 | Nasal polyposis (HP:0100582) | 2.00868578 |
| 121 | Muscle stiffness (HP:0003552) | 2.00784131 |
| 122 | Focal motor seizures (HP:0011153) | 2.00754225 |
| 123 | Neurofibrillary tangles (HP:0002185) | 2.00427296 |
| 124 | Sudden death (HP:0001699) | 1.98662776 |
| 125 | Mitochondrial inheritance (HP:0001427) | 1.97582719 |
| 126 | Lethargy (HP:0001254) | 1.97548734 |
| 127 | Recurrent sinusitis (HP:0011108) | 1.96566650 |
| 128 | Genetic anticipation (HP:0003743) | 1.95129265 |
| 129 | Inability to walk (HP:0002540) | 1.94343620 |
| 130 | Progressive macrocephaly (HP:0004481) | 1.93796614 |
| 131 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93580322 |
| 132 | Tubulointerstitial nephritis (HP:0001970) | 1.92570124 |
| 133 | Dilated cardiomyopathy (HP:0001644) | 1.92080028 |
| 134 | Abnormality of renal resorption (HP:0011038) | 1.91324154 |
| 135 | Hypokalemic alkalosis (HP:0001949) | 1.90523741 |
| 136 | Exercise-induced myalgia (HP:0003738) | 1.90106931 |
| 137 | Abnormality of magnesium homeostasis (HP:0004921) | 1.88684657 |
| 138 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88321334 |
| 139 | Neoplasm of head and neck (HP:0012288) | 1.88278895 |
| 140 | Esophageal neoplasm (HP:0100751) | 1.88278895 |
| 141 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88226839 |
| 142 | Neuroendocrine neoplasm (HP:0100634) | 1.87165179 |
| 143 | Methylmalonic aciduria (HP:0012120) | 1.86062691 |
| 144 | Hypolipoproteinemia (HP:0010981) | 1.84576403 |
| 145 | Hyperphosphaturia (HP:0003109) | 1.84503030 |
| 146 | Occipital encephalocele (HP:0002085) | 1.83499722 |
| 147 | Abnormality of the dental pulp (HP:0006479) | 1.83254735 |
| 148 | Hyperactive renin-angiotensin system (HP:0000841) | 1.80154623 |
| 149 | Urinary urgency (HP:0000012) | 1.80052954 |
| 150 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79725630 |
| 151 | Infantile muscular hypotonia (HP:0008947) | 1.79091270 |
| 152 | Agitation (HP:0000713) | 1.78765957 |
| 153 | Atonic seizures (HP:0010819) | 1.78506480 |
| 154 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76815051 |
| 155 | Hypokalemia (HP:0002900) | 1.76810164 |
| 156 | Dicarboxylic aciduria (HP:0003215) | 1.76300536 |
| 157 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74643512 |
| 158 | Asplenia (HP:0001746) | 1.73932439 |
| 159 | Megalencephaly (HP:0001355) | 1.72922237 |
| 160 | Genital tract atresia (HP:0001827) | 1.72841896 |
| 161 | Infertility (HP:0000789) | 1.72448506 |
| 162 | Intrahepatic cholestasis (HP:0001406) | 1.71730844 |
| 163 | Hypoplasia of the iris (HP:0007676) | 1.70891153 |
| 164 | Spastic gait (HP:0002064) | 1.70283352 |
| 165 | Hyperaldosteronism (HP:0000859) | 1.70188027 |
| 166 | Spontaneous abortion (HP:0005268) | 1.69260344 |
| 167 | Abnormality of potassium homeostasis (HP:0011042) | 1.68239761 |
| 168 | Glycosuria (HP:0003076) | 1.67914097 |
| 169 | Abnormality of urine glucose concentration (HP:0011016) | 1.67914097 |
| 170 | Abnormality of the dental root (HP:0006486) | 1.67631257 |
| 171 | Taurodontia (HP:0000679) | 1.67631257 |
| 172 | Abnormality of permanent molar morphology (HP:0011071) | 1.67631257 |
| 173 | Postaxial foot polydactyly (HP:0001830) | 1.64331464 |
| 174 | Hyperglycinemia (HP:0002154) | 1.63778747 |
| 175 | Molar tooth sign on MRI (HP:0002419) | 1.63714582 |
| 176 | Abnormality of midbrain morphology (HP:0002418) | 1.63714582 |
| 177 | Increased hepatocellular lipid droplets (HP:0006565) | 1.62908097 |
| 178 | Psychosis (HP:0000709) | 1.62110351 |
| 179 | Abnormality of renin-angiotensin system (HP:0000847) | 1.61739131 |
| 180 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.60758428 |
| 181 | Hydroxyprolinuria (HP:0003080) | 1.59497154 |
| 182 | Abnormality of proline metabolism (HP:0010907) | 1.59497154 |
| 183 | Abnormality of molar (HP:0011077) | 1.58996868 |
| 184 | Abnormality of molar morphology (HP:0011070) | 1.58996868 |
| 185 | Cerebral inclusion bodies (HP:0100314) | 1.58523212 |
| 186 | Single umbilical artery (HP:0001195) | 1.58381524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 6.14722095 |
| 2 | STK39 | 4.22789321 |
| 3 | EIF2AK1 | 3.34400582 |
| 4 | OXSR1 | 3.15428917 |
| 5 | MARK3 | 2.98922216 |
| 6 | LATS1 | 2.87273455 |
| 7 | TNIK | 2.86009459 |
| 8 | WNK4 | 2.72519554 |
| 9 | BUB1 | 2.27662583 |
| 10 | PNCK | 2.27541778 |
| 11 | MAP3K9 | 2.25126883 |
| 12 | PBK | 2.20312189 |
| 13 | MUSK | 2.14855473 |
| 14 | SIK1 | 2.09684940 |
| 15 | PKN2 | 2.08898148 |
| 16 | EPHA4 | 2.02979420 |
| 17 | MST4 | 1.99892668 |
| 18 | CDK19 | 1.90342949 |
| 19 | EIF2AK3 | 1.83216887 |
| 20 | SGK223 | 1.70622682 |
| 21 | SGK494 | 1.70622682 |
| 22 | WEE1 | 1.69282741 |
| 23 | ARAF | 1.63781242 |
| 24 | PIK3CG | 1.61646029 |
| 25 | ZAK | 1.59031529 |
| 26 | INSRR | 1.55502223 |
| 27 | WNK3 | 1.51244006 |
| 28 | BRAF | 1.40199857 |
| 29 | EPHB1 | 1.39152958 |
| 30 | WNK1 | 1.37810776 |
| 31 | PKN1 | 1.31565288 |
| 32 | IRAK2 | 1.24144769 |
| 33 | TNK2 | 1.23399767 |
| 34 | IRAK1 | 1.22778638 |
| 35 | AKT3 | 1.21229966 |
| 36 | NTRK3 | 1.18087835 |
| 37 | NME1 | 1.17957270 |
| 38 | PAK3 | 1.15979145 |
| 39 | MAP2K7 | 1.14971376 |
| 40 | NTRK1 | 1.10923046 |
| 41 | MAP3K1 | 1.10148858 |
| 42 | FLT3 | 1.04242086 |
| 43 | NEK2 | 1.02100888 |
| 44 | PHKG2 | 1.01835156 |
| 45 | PHKG1 | 1.01835156 |
| 46 | TSSK6 | 0.97044446 |
| 47 | PINK1 | 0.96820129 |
| 48 | DYRK3 | 0.96786556 |
| 49 | STK38L | 0.94935666 |
| 50 | BMPR1B | 0.94808738 |
| 51 | CAMK2B | 0.94314960 |
| 52 | PLK3 | 0.94104564 |
| 53 | PLK1 | 0.94049335 |
| 54 | FRK | 0.93379475 |
| 55 | MAP3K2 | 0.91981629 |
| 56 | MAP3K7 | 0.91871331 |
| 57 | CAMK2G | 0.91510680 |
| 58 | MAP3K5 | 0.90946144 |
| 59 | MELK | 0.90073977 |
| 60 | LATS2 | 0.90062483 |
| 61 | CAMK2A | 0.89088468 |
| 62 | MAP3K4 | 0.88611681 |
| 63 | CASK | 0.87469041 |
| 64 | NEK6 | 0.87468589 |
| 65 | CAMK1G | 0.87203192 |
| 66 | TAF1 | 0.85582663 |
| 67 | ABL2 | 0.84754615 |
| 68 | MOS | 0.83829276 |
| 69 | MAPKAPK5 | 0.83371491 |
| 70 | CDK3 | 0.82819658 |
| 71 | CAMK2D | 0.82794411 |
| 72 | ROCK2 | 0.82145414 |
| 73 | STK16 | 0.80912535 |
| 74 | LRRK2 | 0.79622774 |
| 75 | MAPKAPK3 | 0.79503451 |
| 76 | DMPK | 0.79072619 |
| 77 | NUAK1 | 0.77284250 |
| 78 | PRKCG | 0.75913040 |
| 79 | BCKDK | 0.75782811 |
| 80 | GRK1 | 0.75620587 |
| 81 | PTK2B | 0.74985973 |
| 82 | TRIM28 | 0.74609048 |
| 83 | CDK5 | 0.70397623 |
| 84 | CAMK1 | 0.70329892 |
| 85 | CSNK1G2 | 0.69240325 |
| 86 | TRPM7 | 0.69189547 |
| 87 | OBSCN | 0.68691922 |
| 88 | SGK2 | 0.68105948 |
| 89 | MAPK12 | 0.67897316 |
| 90 | FGFR2 | 0.67519789 |
| 91 | NME2 | 0.67386270 |
| 92 | MAP2K4 | 0.66359428 |
| 93 | AKT2 | 0.65862087 |
| 94 | MARK2 | 0.65554266 |
| 95 | TTK | 0.65436089 |
| 96 | CSNK1A1L | 0.63703039 |
| 97 | MAP3K12 | 0.62808196 |
| 98 | PRKCQ | 0.62367512 |
| 99 | PIK3CA | 0.62208975 |
| 100 | HIPK2 | 0.62162000 |
| 101 | CSK | 0.61513949 |
| 102 | PRKAA2 | 0.60818456 |
| 103 | UHMK1 | 0.60743259 |
| 104 | BCR | 0.60406364 |
| 105 | NTRK2 | 0.59059652 |
| 106 | AURKB | 0.58820218 |
| 107 | SRPK1 | 0.58454242 |
| 108 | MYLK | 0.56967158 |
| 109 | PRKCH | 0.54478307 |
| 110 | STK3 | 0.54429408 |
| 111 | CSNK1G3 | 0.54183822 |
| 112 | SGK3 | 0.54014784 |
| 113 | CDC42BPA | 0.53235436 |
| 114 | FGFR1 | 0.52779428 |
| 115 | FES | 0.52199161 |
| 116 | STK4 | 0.52178946 |
| 117 | LMTK2 | 0.51649633 |
| 118 | PDK1 | 0.51366720 |
| 119 | TLK1 | 0.51102643 |
| 120 | DYRK2 | 0.49041535 |
| 121 | MINK1 | 0.48891778 |
| 122 | DAPK2 | 0.46623576 |
| 123 | PAK1 | 0.46175163 |
| 124 | MAP3K13 | 0.46109383 |
| 125 | PRKG1 | 0.45744056 |
| 126 | PRKG2 | 0.45382152 |
| 127 | FYN | 0.45355262 |
| 128 | NLK | 0.45005185 |
| 129 | TIE1 | 0.44216922 |
| 130 | CSNK1E | 0.44039019 |
| 131 | PRKCE | 0.43144299 |
| 132 | PRKD2 | 0.42801911 |
| 133 | PRKD1 | 0.42437988 |
| 134 | RPS6KB1 | 0.41714130 |
| 135 | CSNK1G1 | 0.41098265 |
| 136 | RET | 0.39283815 |
| 137 | VRK1 | 0.39127957 |
| 138 | PDPK1 | 0.37582492 |
| 139 | TAOK1 | 0.37369449 |
| 140 | PRKACA | 0.37043561 |
| 141 | ATM | 0.36725150 |
| 142 | INSR | 0.36140078 |
| 143 | ITK | 0.36059862 |
| 144 | GSK3A | 0.35812118 |
| 145 | FER | 0.35767540 |
| 146 | JAK2 | 0.35537440 |
| 147 | KSR2 | 0.35136414 |
| 148 | PRKACB | 0.32751465 |
| 149 | CSNK2A2 | 0.30673126 |
| 150 | MAP3K3 | 0.30358429 |
| 151 | CSNK1A1 | 0.28921236 |
| 152 | ROCK1 | 0.28895795 |
| 153 | RPS6KA5 | 0.28851237 |
| 154 | TTN | 0.27916026 |
| 155 | CDK14 | 0.25817078 |
| 156 | CSNK2A1 | 0.24676347 |
| 157 | NEK1 | 0.21375144 |
| 158 | MAP4K2 | 0.19931349 |
| 159 | AURKA | 0.19319494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.15981556 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05247760 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.96118275 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.89666057 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.40200522 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32141581 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29927511 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.17817887 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.12566910 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.10854963 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.07524263 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99062117 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 1.94007657 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.91064225 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85377399 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.84142196 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.68728197 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.63783803 |
| 19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.59828801 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.57290347 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54688858 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.52206959 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.50629267 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50596940 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49615858 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48150004 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47380577 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46037077 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42783737 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.42274384 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39933121 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.35465661 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32544998 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31344946 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.29700181 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29279781 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25237505 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.24405020 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.23610954 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.22209806 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.20588196 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19003012 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18998833 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16479824 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 1.15044194 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13845948 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11448758 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.09278005 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04902720 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04774155 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03967474 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02370062 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00835760 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00138828 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99548630 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.99003662 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.98929430 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97106835 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96499006 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91998060 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91700354 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90898791 |
| 63 | Morphine addiction_Homo sapiens_hsa05032 | 0.88376428 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87497688 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86852479 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.85728028 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85017961 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.84881841 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82128243 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81578030 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.79122847 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78827673 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77729290 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77632698 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77565076 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77424410 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77130776 |
| 78 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75608083 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75362202 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74408458 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74100863 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73381211 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73368722 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73225112 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72096175 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71420350 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70953906 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70443192 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68646152 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67315468 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66483223 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66016114 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65979864 |
| 94 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.65566179 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65220663 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65047155 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.64568130 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63216708 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63099930 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.62802855 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62201277 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.61443662 |
| 103 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.61427410 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60170108 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59945331 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59579287 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59170824 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.58961772 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58870242 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58827816 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58053439 |
| 112 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57997896 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.56487270 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56360149 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56051450 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55631135 |
| 117 | Ribosome_Homo sapiens_hsa03010 | 0.55591919 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55281518 |
| 119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50358031 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50028165 |
| 121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49577702 |
| 122 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48833162 |
| 123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48448470 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48410048 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47882942 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47483840 |
| 127 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47034054 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46993756 |
| 129 | Nicotine addiction_Homo sapiens_hsa05033 | 0.46094678 |
| 130 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46078293 |
| 131 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45705483 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42016067 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41755975 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40661651 |
| 135 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40582569 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40533964 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40224778 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40037135 |
| 139 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39445395 |
| 140 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38672138 |
| 141 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37784315 |
| 142 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36909280 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.36681408 |
| 144 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31686202 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26781644 |
| 146 | Homologous recombination_Homo sapiens_hsa03440 | 0.25561588 |
| 147 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21752361 |
| 148 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19472063 |
| 149 | RNA transport_Homo sapiens_hsa03013 | 0.17264083 |

